Younger reviews your health history, current symptoms, sleep patterns, and lifestyle then orders targeted lab work including hormone panels, metabolic markers, and nutrient levels
In August 2025, Wegovy received accelerated approval for the treatment of adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver
Strategic Market Positioning Opportunities
Targeting gastrin releasing peptide receptors: new options for the therapy and diagnosis of cancer
Step 2: Get a prescription if eligible
It is about understanding what your body needs, choosing safe tools, building habits you can repeat, and getting support when your plan needs adjustment